Last reviewed · How we verify
Banlangen Granules Anti-seasonal Influenza Study: a Randomized, Double Blind, Positive and Placebo Controlled，Clinical Study. (BLG)
This study aimed to evaluate the efficacy and safety of the nature herbal medicine Banlangen granules in patients infected with seasonal influenza A (H1N1,H3N2) and influenza B virus.
Details
| Lead sponsor | Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited |
|---|---|
| Phase | Phase 4 |
| Status | UNKNOWN |
| Enrolment | 177 |
| Start date | 2012-04 |
| Completion | 2016-11 |
Conditions
- Influenza
Interventions
- placebo of oseltamivir phosphate
- oseltamivir phosphate
- Banlangen (Radix Isatidis) granules
- placebo of Banlangen(Radix Isatidis) granules
Primary outcomes
- Improving the flu-like symptoms, such as fever etc — 21+7days
The primary end point was the duration of illness which was defined as the time from onset of symptoms to the alleviation of the ten influenza-like symptoms including , nasal obstruction, running nose, cough, sore throat, headache, fatigue, myalgia, chills and sweating. - Improving the flu-like symptoms, such as fever etc — 21+7days
The time to defervescence, defined as the time from the first dose of study medication to the time when the body temperature declined to lower than 37.4ºC and was sustained for at least 24 hours.
Countries
China